MOUNT ROYAL, N.J., May 18, 2017 /PRNewswire/ -- Leading clinical researchers on headache disorders, particularly migraine,cluster headache and post-traumatic headache, will present the latest data on new therapies at the American Headache Society (AHS)'s 59th Annual Scientific Meeting. The AHS accepted more than 220 scientific abstracts, which include the latest
Migraine is the leading cause of disability worldwide due to a neurological disease that impacts more than 36 million men, women and children in the United States. For more than 90% of those affected, it interferes with education, career and social activities.
"The studies being presented at the 59th AHS Annual Scientific Meeting show that we're making real progress toward better treatment options for individuals with migraine and a deeper understanding of how the disease affects patient populations," said Peter Goadsby, MD, PhD, FAHS, AHS Scientific Program Committee Chair, Professor of Neurology, King's College London and University of California, San Francisco, and Director, NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital, London. "We're very excited to be presenting such a broad spectrum of data that sheds light on such an incredible medical need, while also bringing hope to individuals living with a disease that often impacts them in the prime of their lives."
Dr. Goadsby will be highlighting the most important and groundbreaking data during a webcast on June 8, 2017 at 9:00 am ET. Additional information and registration details can be found here: https://join.onstreammedia.com/register/ahsmeeting/webcast.
Following is a select list of abstracts for the platform presentations:
Friday, June 9, 2017
Saturday, June 10, 2017
Following is a select list of abstracts that will be presented as posters:
Friday, June 9, 2017
Saturday, June 10, 2017
Online Annual Meeting Press Room:Visit https://americanheadachesociety.org/events/59th-annual-scientific-meeting/ for press guidelines and releases, as well as information on press room, press passes, embargo policies, and photo/video policy.
About Peter Goadsby, MD, PhD, FAHSDr. Peter Goadsby is the AHS Scientific Program Committee Chair; Professor of Neurology, King's College London and University of California, San Francisco; and Director, NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital, London. His major research interests are in the basic mechanisms of primary headache disorders, such as migraine and cluster headache, in both experimental and clinical settings, and translating these insights into their better management.
About MigraineMigraine is a major disabling neurological disease that affects more than 36 million men, women and children in the United States. The disease impacts one in four households, one in five women, one in 16 men and one in 11 children in the United States. Globally, migraine is the sixth highest cause of years of life lost due to disability. Individuals who experience migraine have symptoms that include nausea, sensitivity to light and/or odors, skin sensitivity, fatigue, mood change, dizziness, difficulty concentrating, neck pain and changes in vision, including seeing spots, stars, lines, flashing lights and zigzag lines. The risk of other serious diseases is significantly higher in those with migraine, including stroke, epilepsy, depression, anxiety and chronic pain. Despite this, only one of every three people talk with a doctor about their migraine attacks and of those, only half get the right diagnosis. There is also a massive shortage of specialists focusing on migraine, with one specialist for every 65,000 individuals living with migraine, which worsens the problem.
About the American Headache SocietyThe American Headache Society (AHS) is a professional society of health care providers dedicated to the study and treatment of headache and face pain. The Society's objectives are to promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders. Educating physicians, health professionals and the public and encouraging scientific research are the primary functions of this organization. AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, and publication of the journal Headache. More information can be found at www.americanheadachesociety.org. In 2010 AHS founded the American Migraine Foundation (AMF) to provide access to information and resources for individuals living with migraine, as well as their loved ones. AMF is a non-profit organization dedicated to the advancement of research and awareness surrounding migraine. Patients can learn more, find help and get connected by visiting www.americanmigrainefoundation.org.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/2017-american-headache-society-annual-scientific-meeting-highlights-advances-in-migraine-treatment-and-research-300459674.html
SOURCE The American Headache Society (AHS)
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All